Hypertension, heart failure, and endothelial function

American Journal of Cardiology

Volumn 82, Issue 9 SUPPL. 2, 1998, Pages

  Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL;

BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; ENZYME INHIBITION; HEART FAILURE; HUMAN; HYPERTENSION; LIPID PEROXIDATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION; VITAMIN INTAKE;

EID: 0032548024     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(98)00762-0     Document Type: Article

References (16)

1. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997;20(suppl II):II-26-II-33.
2. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation 1996;94:258-265.
3. Drexler H. Endothelial function in heart failure: some unsolved issues. Eur Heart J 1996;17:1775-1777.
4. Ramsey MW, Goodfellow J, Jones CJH, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995;92:3212-3219.
5. Katz SD. Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol 1997;12:259-264.
6. Katz SD. The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failure. Prog Cardiovasc Dis 1995;38:23-50.
7. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu X-B, Kobari Y, Pritchard K Jr, Sessa WC, Hintze TH. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996; 78:58-64.
8. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996;93:210-214.
9. Belch JJF, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991;65:245-248.
10. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97:363-368.
11. Drexler H, Banhardt U, Meinertz T, Wollschläger H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure: a double-blind, placebo-controlled trial. Circulation 1989;79:491-502.
12. Drexler H, Kurz S, Jeserich M, Münzel T, Hornig B. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol 1995;76(suppl):13E-18E.
13. Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997; 95:1115-1118.
14. Hornig B, Arakawa N, Haussmann D, Drexler H. ACE-inhibition with quinapril improves endothelial function in patients with chronic heart failure due to increased availability of nitric oxide: potential role of affinity to tissue ACE. Circulation 1998 (in press).
15. Nakamura M, Chiba M, Ueshima K, Arakawa N, Yoshida H, Makita S, Kawazoe K, Hiramori K. Effects of mitral and/or aortic valve replacement or repair on endothelium-dependent peripheral vasorelaxation and its relation to improvement in exercise capacity. Am J Cardiol 1996;77:98-102.
16. Drexler H. The endothelium as a therapeutic target in heart failure. Circulation 1998 (in press).